About Us | Pharming Group N.V. Remuneration Policy for the Board of Directors dr. de vries also held senior business and commercial positions at novartis, novartis ophthalmics and at smithkline beecham pharmaceuticals plc. Pharming Group announces the intention to nominate three Non-Executive Pharming Group Announces the Nomination of Barbara Yanni and Mark C1INH is a naturally occurring protein that downregulates the complement cascade in order to control swelling in affected tissues. Total revenues increased by 4% during the first half of 2022 to US$96.8 million, versus US$93.2 million during the first half of 2021.. Board Rules of Pharming Group N.V. 3.9 The acceptance by an Executive Director of a position as supervisory director or non-executivedirector with another company or entity shall be subject to the approval of the Board. Paul Sekhri, Chairman of the Board of Supervisory Directors, commented: "We are thrilled to nominate Barbara Yanni and Mark Pykett as new members of the Board of Supervisory Directors. Special competencies Pharming Group announces the intention to nominate three Non-Executive Pharming Group N.V. is a specialty pharmaceutical company developing innovative products for the safe, effective treatment of rare diseases and unmet medical needs. SEC Filings Annual Reports Quarterly Results. The information has been provided by the organisation. Board of Directors Corporate Governance Executive Committee Pharming has a one-tier board structure. S. Baert - Pharming Group N.V. - Leiden Below you will find information from the register notifications directors and members of the supervisory board. Pharming Group N.V. presents its preliminary, unaudited financial report for the first nine months ended September 30, 2022. Please contact us at: investor@pharming.com or fill in our contact form linked below. Pharming has a one-tier board structure. Revenues for the first nine months of 2022 were US$151.0 million, a 3% increase compared to the first nine months of 2021 (US$146.1 million).. From 2017 to 2020, Mr. Toor was the Senior Vice President and General Manager, US. News Releases | Pharming Group N.V. Board of Directors Steven Altschuler, M.D. We regularly present at conferences and corporate and scientific presentation materials are also made available on our website. Pharming Group announces the intention to nominate three Non - Insider Published: 12:08 PM EDT October 28, 2022. OIF appoints Board of Directors. The board of directors at pharmaceutical giant Merck elected Robert Davis as chairman, effective Dec. 1. Board of Directors | Pharming Group N.V. The Company held an analyst conference . OIF appoints Board of Directors ~ Converge! Network Digest The Board of Management will propose (i) whether the criteria for granting Options have been met by a potential Participant, and (ii) the number of Options to be granted to such Participant. Casey Lynch Board Member Phillip Schneider Board Member Paul Sekhri The nominations will be subject to shareholders' approval at the upcoming Annual General Meeting of Shareholders, which will take place on 30 April 2015. Leiden, The Netherlands, September 26, 2008. Our innovative technology and processes are aimed at purification and formulation of these products. | July 12, 2022 Pharming Group Announces the Nomination of Barbara Yanni and Mark Pykett to the Board of Supervisory Directors PR Newswire LEIDEN, Netherlands, May 20, 2020 Jorn - Pharming Group N.V. - Leiden Below you will find information from the register notifications directors and members of the supervisory board. Juergen Ernst to retire from Pharming's Board of Supervisory Directors Pharming Group's Board of Supervisory Directors Nominates - BioSpace The flagship of our portfolio is our recombinant human C1 esterase inhibitor, or rhC1INH, franchise. Pharming Group N.V. has nominated Paul Jai Sekhri and Jan Hendrik Egberts as members of the Board of Supervisory Directors. Paul Sekhri, Chairman of the Board of Supervisory Directors, . Pharming Group Announces the Nomination of Barbara Yanni and Mark Dr Pinto to retire after completion of transition period Leiden, The Netherlands, September 26, 2008. Until that moment, Barbara Yanni and Mark Pykett will hold an observational role within Pharming's Board of Supervisory Directors. Incannex Healthcare Quarterly Activities Report and Appendix 4C | IXHL dr. de vries holds an md degree from the university of amsterdam and an mba in general management from ashridge Gross profit for . Grew the business by $800 million in 6 years. If you need information other than presented here, please consult our FAQ section or contact our Investor Relations department. Pharming Group announces the nomination of Barbara Yanni and Mark Deborah Jorn | Board Member | Pharming Group N.V. prior to joining pharming, dr. de vries was the ceo of 4-antibody and morphochem ag. Board of directors Martin Nicklasson Chairman of the Board Chairman of the Remuneraation Committee and of the Nomination Committee; member of the Audit Committee. H1 2022. Ms. Debora Jorn, a member of the BOSD, will succeed Juergen as Vice-Chair. Pharming may grant Options to any Employee. PHARMING GROUP : Board of Supervisory Directors nominates new CEO determined by the Board of Management and approved by the Board of Supervisory Directors. Pharming Group announces the intention to nominate three Non-Executive Directors to the Board of Directors PR Newswire LEIDEN, Netherlands, March Pharming Group today announces that its Vice-Chair, Juergen Ernst, has, for personal reasons, decided to retire from the Board of Supervisory Directors (BOSD), effective immediately. Pharming expects to nominate a new member of the BOSD for approval by the shareholders at the next Annual General Meeting in April 2009. The Board of Directors is jointly responsible for the management of the Company. Board Member, Executive Committee - Pharming Group N.V. Ms. Jorn was Executive Vice President of Corporate and Commercial Development at Eyepoint Pharmaceuticals from 2016 to 2018. Nominations to Pharming's Board Of Supervisory Directors Gross profit increased by 5% . Cathy Liu, Broadcom Inc., was re-elected to the Board (two-year term) and continues as President. Date of transaction 27 oct 2022; Person obliged to notify D.A. . Juergen Ernst to retire from Pharming's Board of Supervisory Directors An Extraordinary General Meeting of Shareholders is expected to be convened later this year for their official appointment. AIM ImmunoTech Board Issues Letter to Shareholders Merck CEO to serve as board chairman Dr. de Vries is on the Board of Directors of Pharming's fill & finish partner, BioConnection B.V. and is also a non-executive director of Midatech Pharma plc. Pharming Group N.V. announces the nomination of Barbara Yanni and Mark Pykett to its Board of Supervisory Directors. Pharming Group Announces Change In Composition Of Board Of Supervisory An Executive Director shall notify the Board in advance of any other position he/she wishes to pursue. Documents & Charters Board of Directors Executive Committee Committee Composition. Ex-3.2 - Sec LEIDEN, Netherlands, Nov. 23, 2020 /PRNewswire/ -- Pharming Group N.V. (Euronext Amsterdam: PHARM) announces that its Vice-Chair, Juergen Ernst, has, for personal reasons, decided to retire from. From July 2007 through December 2016, he served as Senior Vice President and Chief Financial Officer of Momenta Pharmaceuticals Inc., a publicly traded biotechnology company, and was its Vice President and Chief Financial . . Coulter Partners secures Supervisory Board Directors for Pharming Group Pharming Group N.V. is a specialty pharmaceutical company developing innovative products for the safe, effective treatment of rare diseases and unmet medical needs. Led the global marketing team for Merck's Ace Inhibitor Franchise. Pharming Group, Leiden, The Netherlands Sijmen de Vries, CEO: T: +31 71 524 7400 Susanne Embleton, Investor Relations Manager: T: +31 71 524 7400, E: s.embleton@pharming.com FTI Consulting,. Remuneration Policy for the Board of Directors This Remuneration Policy was adopted by the General Meeting of Shareholders of Pharming Group N.V. (hereafter the" ompany" or "Pharming") on 11 December 2020 (hereafter the "Remuneration Policy or "Policy") and outlines the remuneration structure for members of the Board of Directors of Pharming Group: all proposals Annual General Meeting of Shareholders Career opportunities | Pharming Group N.V. Until that moment, Barbara Yanni and Mark Pykett will hold Chair of the Corporate Governance Committee Member of the Audit Committee Shareholder Tools Pharming Group announces the intention to nominate three Non-Executive Nornickels Board of Directors Recommends New Directors Paul Sekhri, Chairman of the Board of . Ms. Debora Jorn, a member of the BOSD, will succeed Juergen as Vice-Chair. Pharming has in place adequate internal controls for the management of the Company and . The Toledo-based health system . About - Longboard Pharmaceuticals Pharming Group N.V. specializes in rare and ultra-rare diseases and aims to become a sustainable, fast-growing, and fully integrated global biotechnological company. Article 4. Bio Details Deborah Jorn , MBA Vice-Chair of the Board of Directors and Member of the Audit Committee Ms. Jorn has been on the Board of Directors since 2019. - NETHERLANDS, Leiden - Pharming Group N.V. (EURONEXT: PHARM) today announces the nominations of Paul Jai Sekhri and Jan Hendrik Egberts as members of its Board of Supervisory Directors. . Financial highlights . ProMedica CEO Randy Oostra retiring | wtol.com | June 15, 2022 Coulter Partners secures Supervisory Board Directors for Pharming Group YTD Q3 2022. Pharming Group reports earnings for the first nine months of 2022 The shareholders adopted the financial statements for the 2021 financial year (agenda item 2.e); approved the proposal to grant discharge to the members of the Board of Directors for the 2021 . Pharming Group N.V. presents its preliminary (unaudited) financial report for the first six months of 2022 ended June 30, 2022. Marco Peters, Ph.D. Vice President and Head of Translational Science Nuggehally "Srini" Srinivas, Ph.D. Vice President, Clinical Pharmacology Board of Directors President and CEO Vincent Aurentz Board Member Corinne Le Goff, Pharm.D. Jorn; Previous result . Until that moment, Barbara Yanni and Mark Pykett will hold an observational role within Pharming's Board of Supervisory Directors. OIF announced its newly elected Board of Directors and Officers. Coulter Partners was delighted to partner recently with Pharming Group N.V. (Euronext Amsterdam: PHARM), to secure the nomination of Barbara Yanni and Mark Pykett to the Board of Supervisory Directors. Jabine van der Meijs | Board Member | Pharming Group N.V. LEIDEN, THE NETHERLANDS--(Marketwire - August 18, 2010) - Biotech company Pharming Group NV ("Pharming" or "the Company") (NYSE Euronext: PHARM) announced today that the Board of Supervisory Directors (BOSD) has nominated Dr Karl Keegan for appointment as Chief Financial Officer (CFO) and member of the Board of Management of Pharming. D.A. Jorn - Pharming Group N.V. - Leiden | Register notifications The Company will host a presentation for analysts at today October 27, 2022 at 13:30 CET/07:30 ET. Our lead product, RUCONEST is the first and only plasma-free rhC1INH protein replacement therapy. The information has been provided by the organisation. | May 5, 2022 Joanne Beck, Ph.D. John Curnutte, M.D., Ph.D. Marc Dunoyer Bobby Gaspar, M.D., Ph.D. Chief Executive Officer Jim Geraghty Chairman of the Board Charles Rowland, Jr. Alicia Secor Executive Committee | Pharming Group N.V. T. Jeff Hutchins, Ranovus, was re-elected to the Board (one-year term) and continues as Physical & Link Layer Working Group - Co-Packaging Vice Chair. Investors | Pharming Group N.V. Leiden, The Netherlands, December 1, 2008. Board of Directors - Synlogic Therapeutics Pharming Group announces the intention to nominate Steven Baert, Leon Kruimer and Jabine van der Meijs as Non-Executive Directors to the Board. The daily management of the Company and the execution of the strategy are entrusted to the CEO, supported by the Executive Committee. Pharming : Nominates Paul Sekhri And Jan Egberts As Members Of Its Pharming N : Juergen Ernst to retire from Pharming's Board of Coulter Partners secures Supervisory Board Directors for Pharming Group An Extraordinary General Meeting of Shareholders is expected to be convened later this year for Financial Information. Executive Committee | Pharming Group N.V. Shareholder Services. LEIDEN, Netherlands - Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) (Nasdaq: PHAR) announces the intention to nominate Steven Baert, Leon Kruimer and Jabine van der Meijs as Non-Executive Directors to the Board. The daily management of the Company and the execution of the strategy are entrusted to the CEO, supported by the Executive Committee. Juergen Ernst to retire from Pharming's Board of Supervisory Directors Elected to the Board in 2015 and regarded as an independent board member. Pharming Group announces Paul Sekhri and Jan Egberts to its Supervisory Pharming Nominates Paul Sekhri And Jan Egberts As Members Of Its Board Of Supervisory Directors LEIDEN, THE NETHERLANDS, 19 March 2015 - Pharming. Biotech company Pharming Group NV announced today that the. Boards. Text Size. Pharming Group announces the intention to nominate three Non-Executive Support: 888-992-3836 | NewsWire | Home | Login / Register. Clinical stage pharmaceutical development company, Incannex Healthcare Limited (ASX: IHL) (NASDAQ: IXHL), ('Incannex' or the Biotech company Pharming Group NV ("Pharming" or "the Company") (NYSE Euronext: PHARM) announced today that the Board of Supervisory Directors (BOSD) has nominated Dr Sijmen de Vries, currently CEO of 4-Antibody in Basel, Switzerland, for appointment as Chief Executive Officer of Pharming to succeed Dr Francis J. Pinto. Pharming Group''s Supervisory Board Nominates CFO | BioSpace Pharming Group reports financial results for the first half of 2022 Mr. Davis has served as company president since April 2021 and CEO and . D.A. Board of Directors Pharming has a one-tier board structure. Pharming Group announces the intention to nominate three Non-Executive Pharming Group, Leiden, The Netherlands Sijmen de Vries, CEO: T: +31 71 524 7400 Susanne Embleton, Investor Relations Manager: T: +31 71 524 7400, E: s.embleton@pharming.com FTI Consulting,. Corporate governance | Pharming Group N.V. Prior to Pharming, Mr. Toor was Senior Director, Sales and Marketing - Immunology, Orphan and . The Board of Directors is jointly responsible for the management of the Company. Team - Orchard Therapeutics Financial highlights . OCALA, Fla., October 26, 2022--The Board of Directors ("Board") of AIM ImmunoTech Inc. (NYSE: American AIM) ("AIM" or the "Company") today issued a letter to shareholders to correct the record . Pharming Group, Leiden, The Netherlands Sijmen de Vries, CEO: T: +31 71 524 7400 Susanne Embleton, Investor Relations Manager: T: +31 71 524 7400 E: investor@pharming.com FTI Consulting, London, UK Victoria Foster Mitchell/Alex Shaw/Mary Whittow T: +44 203 727 1000 LifeSpring Life Sciences Communication, Amsterdam, The Netherlands Leon Melens TOLEDO, Ohio ProMedica CEO Randy Oostra is retiring, effective Monday. LEIDEN, Netherlands, May 20, 2020 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) announces the nomination of Barbara Yanni and Mark Pykett to. Director and Acting Head Ace Inhibitor Franchise. Deb Jorn - Member Board Of Directors - Diurnal Ltd | LinkedIn Mr Jaap Blaak, Chairman of Pharming's Board of Supervisory Directors said: "Pharming is very grateful to Dr. Veltman who has served on the Board for almost seven years including a few years as chairman. Biotech company Pharming Group NV announced today that Prof. Dr. B.P.Th. Listen. MMC Norilsk Nickel (MNOD) NORNICKELS BOARD OF DIRECTORS RECOMMENDS NEW DIRECTORS 28-Oct-2022 / 18:00 MSK Dissemination of a Regulatory Announcement, transmitted by EQS Group. Board of Directors Zealand pharma LEIDEN, Netherlands, Nov. 23, 2020 /PRNewswire/ -- Pharming Group N.V. (Euronext Amsterdam: PHARM) announces that its Vice-Chair, Juergen Ernst, has, for personal reasons, decided to retire from the Board of Supervisory Directors (BOSD), effective immediately. Veltman has notified the Company that he will retire from the Board of . Pharming Group Announces the Nomination of Barbara Yanni and - Insider Pharming Group reports earnings for the first nine months of 2022 Rick previously served as a member of the Syndax Pharmaceuticals board of directors from January 2014 to February 2017. Ex-10.1 - Sec S. Baert - Pharming Group N.V. - Leiden | Register notifications Their official appointments will be confirmed by the Company's Annual General Meeting of Shareholders that will be held on 19 May 2021. May 1989 - Jun 19967 years 2 months. The daily management of the Company and the execution of the strategy are entrusted to the CEO, supported by the Executive Committee. The nominations will be subject to shareholders' approval at the upcoming Annual General Meeting of Shareholders, which will take place on 30 April 2015. Ms. Van der Meijs holds a Master of Science (Pharmacy) and a Doctor of Pharmacy (Pharm D) degree from the University of Utrecht, and she completed her professional accounting degree in the UK with the Chartered Institute of Management Accountants (ACMA). PHARMING GROUP : announces change in composition of Board Of Pharming Group announces the intention to nominate three Non-Executive Directors to the Board of Directors PR Newswire LEIDEN, Netherlands, March 23, 2021 LEIDEN, Netherlands, March 23, 2021 /PRNew. About Us. Updated: 12:08 PM EDT October 28, 2022. The Board of Directors is jointly responsible for the management of the Company.